![Human Epidermal Growth Factor Receptor 2 (HER2) in Cancers: Overexpression and Therapeutic Implications Human Epidermal Growth Factor Receptor 2 (HER2) in Cancers: Overexpression and Therapeutic Implications](https://static.hindawi.com/articles/mbi/volume-2014/852748/figures/852748.fig.002d.jpg)
Human Epidermal Growth Factor Receptor 2 (HER2) in Cancers: Overexpression and Therapeutic Implications
![AstraZeneca on Twitter: "Approx. 20-30% of #breastcancer have a faulty HER2 gene which makes too many copies of itself – this is known as gene amplification. This results in more HER2 receptors AstraZeneca on Twitter: "Approx. 20-30% of #breastcancer have a faulty HER2 gene which makes too many copies of itself – this is known as gene amplification. This results in more HER2 receptors](https://pbs.twimg.com/media/ELmJtymVAAEJpCe.png:large)
AstraZeneca on Twitter: "Approx. 20-30% of #breastcancer have a faulty HER2 gene which makes too many copies of itself – this is known as gene amplification. This results in more HER2 receptors
![Automated detection of the HER2 gene amplification status in Fluorescence in situ hybridization images for the diagnostics of cancer tissues | Scientific Reports Automated detection of the HER2 gene amplification status in Fluorescence in situ hybridization images for the diagnostics of cancer tissues | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-019-44643-z/MediaObjects/41598_2019_44643_Fig1_HTML.png)
Automated detection of the HER2 gene amplification status in Fluorescence in situ hybridization images for the diagnostics of cancer tissues | Scientific Reports
![Frontiers | Current Therapies for Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer Patients Frontiers | Current Therapies for Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer Patients](https://www.frontiersin.org/files/Articles/306736/fonc-08-00089-HTML-r2/image_m/fonc-08-00089-g001.jpg)
Frontiers | Current Therapies for Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer Patients
![Cancers | Free Full-Text | Targeted Therapeutic Options and Future Perspectives for HER2-Positive Breast Cancer Cancers | Free Full-Text | Targeted Therapeutic Options and Future Perspectives for HER2-Positive Breast Cancer](https://pub.mdpi-res.com/cancers/cancers-14-03305/article_deploy/html/images/cancers-14-03305-g001.png?1657252049)
Cancers | Free Full-Text | Targeted Therapeutic Options and Future Perspectives for HER2-Positive Breast Cancer
![A gene-protein assay for human epidermal growth factor receptor 2 (HER2): brightfield tricolor visualization of HER2 protein, the HER2 gene, and chromosome 17 centromere (CEN17) in formalin-fixed, paraffin-embedded breast cancer tissue sections A gene-protein assay for human epidermal growth factor receptor 2 (HER2): brightfield tricolor visualization of HER2 protein, the HER2 gene, and chromosome 17 centromere (CEN17) in formalin-fixed, paraffin-embedded breast cancer tissue sections](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2F1746-1596-7-60/MediaObjects/13000_2012_Article_585_Fig1_HTML.jpg)
A gene-protein assay for human epidermal growth factor receptor 2 (HER2): brightfield tricolor visualization of HER2 protein, the HER2 gene, and chromosome 17 centromere (CEN17) in formalin-fixed, paraffin-embedded breast cancer tissue sections
![HER2 activation. A, receptor dimerization is required for HER2 function... | Download Scientific Diagram HER2 activation. A, receptor dimerization is required for HER2 function... | Download Scientific Diagram](https://www.researchgate.net/profile/Ray-Mernaugh/publication/40686569/figure/fig1/AS:601622631698458@1520449421391/HER2-activation-A-receptor-dimerization-is-required-for-HER2-function-8-In-the.png)
HER2 activation. A, receptor dimerization is required for HER2 function... | Download Scientific Diagram
![How Herceptin® (trastuzumab) is Thought To Work | Herceptin® (trastuzumab) for HER2+ Early Breast Cancer How Herceptin® (trastuzumab) is Thought To Work | Herceptin® (trastuzumab) for HER2+ Early Breast Cancer](https://www.herceptin.com/content/dam/gene/herceptin/patient/images/herceptin-mechanism-of-action-mobile.genecoreimg.480.jpg)